These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. Amikacin induced renal damage and the role of the antioxidants on neonatal rats. Kara A; Cetin H; Oktem F; Metin Ciris I; Altuntas I; Kaya S Ren Fail; 2016 Jun; 38(5):671-7. PubMed ID: 26982694 [TBL] [Abstract][Full Text] [Related]
85. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269 [TBL] [Abstract][Full Text] [Related]
86. Low serum albumin and the increased risk of amikacin nephrotoxicity. Contreras AM; Ramírez M; Cueva L; Alvarez S; de Loza R; Gamba G Rev Invest Clin; 1994; 46(1):37-43. PubMed ID: 8079062 [TBL] [Abstract][Full Text] [Related]
87. Low molecular weight proteinuria in Chinese herbs nephropathy. Kabanda A; Jadoul M; Lauwerys R; Bernard A; van Ypersele de Strihou C Kidney Int; 1995 Nov; 48(5):1571-6. PubMed ID: 8544416 [TBL] [Abstract][Full Text] [Related]
88. Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy? Havali C; Gücüyener K; Buyan N; Yılmaz Ü; Gürkaş E; Gülbahar Ö; Demir E; Serdaroğlu A J Child Neurol; 2015 Mar; 30(3):301-6. PubMed ID: 24958008 [TBL] [Abstract][Full Text] [Related]
89. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients. Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208 [TBL] [Abstract][Full Text] [Related]
90. [Studies on the intravenous administration of amikacin to neonates]. Masumi R; Hirama Y; Narita A; Nakazawa S; Iwasaki A; Niino K; Sato H; Nakazawa S; Tazoe K; Chikaoka H Jpn J Antibiot; 1987 Jun; 40(6):1146-56. PubMed ID: 3669297 [TBL] [Abstract][Full Text] [Related]
91. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy. Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460 [TBL] [Abstract][Full Text] [Related]
92. A comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/teicoplanin. Fauconneau B; Pariat C; Bouquet S; Piriou A; Ingrand P; Courtois P Ren Fail; 1993; 15(4):469-73. PubMed ID: 8105516 [TBL] [Abstract][Full Text] [Related]
93. Auditory brainstem response in young burn-wound patients treated with ototoxic drugs. Hall JW; Herndon DN; Gary LB; Winkler JB Int J Pediatr Otorhinolaryngol; 1986 Dec; 12(2):187-203. PubMed ID: 3570684 [TBL] [Abstract][Full Text] [Related]
94. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit. Girardi A; Galletti S; Raschi E; Koci A; Poluzzi E; Faldella G; De Ponti F Ital J Pediatr; 2017 Apr; 43(1):37. PubMed ID: 28412957 [TBL] [Abstract][Full Text] [Related]
95. Effects of chronic lithium on ototoxicity induced by gentamicin and amikacin in guinea-pigs. Sharifzadeh M; Abdollahi M; Behrooz H; Minaii B; Kebriaeezadeh A; Kashani MR; Dehpour AR; Aghaebrahimi N Pharmacol Toxicol; 1998 Nov; 83(5):220-4. PubMed ID: 9834971 [TBL] [Abstract][Full Text] [Related]
96. Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy. Singu BS; Ndeunyema MN; Ette EI; Pieper CH; Verbeeck RK BMC Pediatr; 2023 Jan; 23(1):24. PubMed ID: 36647065 [TBL] [Abstract][Full Text] [Related]
97. Impact of Therapeutic Drug Monitoring on Once-Daily Regimen of Amikacin in Patients With Urinary Tract Infection: A Prospective Observational Study. Jayakumar I; Mathaiyan J; Mandal J; Deepanjali S; Sreenivasan SK Ther Drug Monit; 2020 Dec; 42(6):841-847. PubMed ID: 32947556 [TBL] [Abstract][Full Text] [Related]
98. Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates. Zhao W; Biran V; Jacqz-Aigrain E Clin Pharmacokinet; 2013 Dec; 52(12):1127-34. PubMed ID: 24027065 [TBL] [Abstract][Full Text] [Related]
99. Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration. Beaubien AR; Ormsby E; Bayne A; Carrier K; Crossfield G; Downes M; Henri R; Hodgen M Antimicrob Agents Chemother; 1991 Jun; 35(6):1070-4. PubMed ID: 1929245 [TBL] [Abstract][Full Text] [Related]